Zentalis Pharmaceuticals Market Sentiment

Zentalis Pharmaceuticals Inc

ZNTLNASDAQ

$2.01

0.03151.59%

Ult. Agg.: Oct 28, 8:57 AM

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzo Dati finanziariSentimentAzionariato Confronta Opzioni Rapporto azionario

Zentalis Pharmaceuticals Market Sentiment - Benzinga

Zentalis Pharmaceuticals Market Sentiment

Market sentiment signals for Zentalis Pharmaceuticals (ZNTL): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 7.4% short float

Options Flow▲ 0.65 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

14 analysts

Options Flow (P/C)

0.65

More calls — Bullish

154 calls · 100 puts

Avg Consensus PT

+329.0%

Highest Price Target

$20

+894.3%

Oppenheimer

Lowest Price Target

+9.4%

UBS

Short Interest

7.4%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 19, 2026	HC Wainwright & Co.	Andres Y. Maldonado—	+397.1%	$10 → $10	Maintained	Buy
Oct 5, 2026	Leerink Partners	Asthika Goonewardene—	+297.7%	$4 → $8	Assumes	Market Perform→Outperform
Sep 16, 2026	William Blair	Matt Phipps—	—	—	Initiate	Outperform
Jul 23, 2026	Rodman & Renshaw	——	+446.9%	$11	Initiate	Buy
Jul 17, 2026	Mizuho	Graig Suvannavejh—	+297.7%	$8	Initiate	Outperform
Apr 10, 2026	Guggenheim	Michael Schmidt—	+397.1%	$6 → $10	Maintained	Buy
Mar 27, 2026	Guggenheim	Michael Schmidt—	+198.3%	$6 → $6	Maintained	Buy
Nov 12, 2025	Morgan Stanley	Matthew Harrison—	+98.9%	$8 → $4	Maintained	Equal-Weight
Aug 7, 2025	Wells Fargo	Derek Archila—	+148.6%	$6 → $5	Maintained	Equal-Weight
May 15, 2025	Wedbush	Robert Driscoll—	+98.9%	$4 → $4	Maintained	Neutral
May 15, 2025	HC Wainwright & Co.	Andres Maldonado—	+397.1%	$10 → $10	Maintained	Buy
Mar 28, 2025	Wedbush	Robert Driscoll—	+98.9%	$4 → $4	Maintained	Neutral
Mar 27, 2025	HC Wainwright & Co.	Andrew Fein—	+397.1%	$10 → $10	Maintained	Buy
Mar 17, 2025	HC Wainwright & Co.	Andrew Fein—	+397.1%	$10 → $10	Maintained	Buy
Jan 30, 2025	Wells Fargo	Derek Archila—	+198.3%	$8 → $6	Maintained	Equal-Weight
Jan 29, 2025	HC Wainwright & Co.	Andrew Fein—	+397.1%	$20 → $10	Maintained	Buy
Jan 28, 2025	UBS	Eliana Merle—	+9.4%	$5 → $2	Maintained	Neutral
Nov 15, 2024	Guggenheim	Michael Schmidt—	+297.7%	$12 → $8	Maintained	Buy
Nov 15, 2024	HC Wainwright & Co.	Andrew Fein—	+894.3%	$20 → $20	Maintained	Buy
Sep 16, 2024	Oppenheimer	Matthew Biegler—	+894.3%	$20 → $20	Maintained	Outperform
Aug 12, 2024	Wedbush	Robert Driscoll—	+98.9%	$4	Upgrade	Underperform→Neutral
Aug 12, 2024	HC Wainwright & Co.	Andrew Fein—	+894.3%	$20 → $20	Maintained	Buy
Jun 20, 2024	UBS	Eliana Merle—	+148.6%	$28 → $5	Downgrade	Buy→Neutral
Jun 18, 2024	Wells Fargo	Derek Archila—	+347.4%	$29 → $9	Downgrade	Overweight→Equal-Weight
Jun 18, 2024	Stifel	Bradley Canino—	+397.1%	$32 → $10	Maintained	Buy